'Blocking Patent' Doctrine May Now Apply To All Technologies
On Oct. 7, the U.S. Supreme Court denied the petition for certiorari in Acorda Therapeutics Inc. v. Roxane Laboratories Inc.[1] That petition[2] sought review of the so-called "blocking patent" doctrine, under...To view the full article, register now.
Already a subscriber? Click here to view full article